SII to acquire 20% stake in needle-free tech company IntegriMedical
Vaccine
manufacturer Serum Institute of India (SII) announced an investment in
IntegriMedical, a medical technology company developing needle-free injection systems (N-FIS). This collaboration aims to advance N-FIS technology
and make it more accessible to patients globally.
SII will
acquire a 20 per cent stake in IntegriMedical. This investment is expected to
accelerate the development and commercialisation of N-FIS, offering a more
comfortable and painless vaccination experience. N-FIS technology uses a
high-velocity jet stream to administer medications, eliminating needle phobia
and needle-stick injuries. This aligns with SII's mission of "Health for
All" and IntegriMedical's goal to "Transform Healthcare
Globally."
Comments
Post a Comment